Items Tagged with 'Primary Care'


article image

What’s New in Idiopathic Pulmonary Fibrosis? An Interactive Case Study

CME: 0.25
COVID-19 imposes a high burden on patients with (IPF) who are at increased risk for complications and mortality. Using an interactive case study, interstitial lung disease expert Dr Lisa H. Lancaster will navigate the challenges of distinguishing signs and symptoms of COVID-19 from IPF exacerbations, adverse events of IPF medications, and other potential conditions. In addition, Dr Lancaster will share evidence-based strategies for COVID-19 treatment and prevention, and credible, web-based COVID-19 resources that are specific to patients with IPF will be provided.
Read More